Pantoprazole Tillomed Laboratories

Pantoprazole, the active ingredient in Pantoprazole Tillomed Laboratories, is a proton pump inhibitor presented as a solid oral dosage form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazole Tillomed Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: accelerates mucosal healing in patients with endoscopically confirmed erosion. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence: excess gas formation. - Constipation: occasional bowel habit change. - Dry mouth: reduced salivary flow.

Serious or Rare Side Effects: - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, tremor, or cardiac arrhythmia. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Liver enzyme elevation: signs of hepatic injury.

When prescribing Pantoprazole, clinicians should consider several safety aspects: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term users: watch for bone density loss and magnesium deficiency. - Pregnancy and lactation: use only if the potential benefit outweighs risk. - Elderly patients: start at the lowest effective dose and monitor for falls. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (e.g., atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect, potentially increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate (high dose): reduced renal clearance; check serum levels. - Digoxin: slight rise in serum concentration; observe for toxicity signs.